News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
149 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Over 1,000 Multiple Brain Metastases Patients Treated With Brainlab Indication-Specific Software
The treatment plans, generated by this automated software from BrainLAB, eliminate bias induced by the treatment time.
November 16, 2017
·
3 min read
Business
Shineco Enters Into Strategic Cooperation Agreement With Western Xinjiang Tiansheng Agricultural Development Co., Ltd.
Pursuant to the Agreement, Shineco intends to acquire 51%-60% equity interest in Xinjiang Tiansheng’s shares in exchange for consideration consisting of cash and Shineco’s newly issued shares, subject to a definitive agreement to be entered in by the parties.
November 16, 2017
·
4 min read
Pharm Country
Teleflex Announces Public Offering of $500M of Senior Notes
The interest rate and other terms of the Notes will be determined at pricing.
November 16, 2017
·
3 min read
BioCapital
RegeneRx’s Tβ4’s Role in Treatment of Eye Diseases Showcased at 5th International Thymosin Symposium
In his talk, Dr. Sosne presented data demonstrating Tβ4’s important role in corneal wound healing at the benchtop and in his clinical experiences
November 16, 2017
·
4 min read
Policy
Carestream Shows New Optional Advanced Metal Artifact Reduction Software for OnSight 3D Extremity System
The company’s new metal artifact reduction software is pending FDA 510(k) Clearance.
November 16, 2017
·
3 min read
BioMidwest
Kemin Industries Release: Neumentix Clinical Study Shows Sustained Attention Benefits
The new study used CNS Vital Signs test to evaluate the effects of Neumentix supplementation on cognitive performance compared to placebo.
November 16, 2017
·
2 min read
Business
Johns Hopkins Gets a $65M Boost to Take Promising Drugs Into Clinic
Deerfield and Johns Hopkins announce Bluefield Innovations, a collaboration designed to catalyze the development of early stage therapeutics.
November 16, 2017
·
2 min read
Business
WIRB-Copernicus Group Partners With Veeva Systems
WIRB-Copernicus Group , the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it is partnering with Veeva Systems to improve the speed and accuracy of IRB document transfer.
November 16, 2017
·
2 min read
Mallinckrodt Presents Health Economic Data on OFIRMEV (acetaminophen) Injection at ASRA 16th Annual Pain Medicine Meeting
Mallinckrodt announced results from two retrospective, claims-based analyses providing health economic insights on the use of OFIRMEV (acetaminophen) injection - IV acetaminophen - versus oral acetaminophen for managing postoperative pain in patients undergoing bariatric surgery or appendectomy.
November 16, 2017
·
9 min read
Previous
15 of 15